Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsDr. Nikolas Fechner University of Tübingen, Germany
1 TalkBiography
Nikolas Fechner is currently working in the computational drug discovery at Eli Lilly UK. He did his postgraduate research at the University of Tübingen on the application of kernel-based machine learning techniques in drug research, after finishing his Bioinformatics studies at the University of Tübingen.